Close Menu
    Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Antimicrobial Resistance

    MIT Researchers Make Progress on Antibiotic Resistance Under DTRA-JSTO Research Program

    By Global Biodefense StaffOctober 12, 2021
    Colorized scanning electron micrograph of E. coli. Credit: NIAID
    Share
    Facebook LinkedIn Reddit Email

    Researchers are making significant progress in antibiotic resistance under the Discovery of Medical Countermeasures Against New and Emerging threats (DOMANE) program of the Defense Threat Reduction Agency’s (DTRA) Chemical and Biological Technologies Department in its role as the Joint Science and Technology Office (JSTO) for Chemical and Biological Defense.

    A research team at the Massachusetts Institute of Technology (MIT) discovered a new pathway used by E. coli bacteria for escaping antibiotic control.

    When an antibiotic-resistant bacteria spreads unchecked, it poses a significant threat to military servicemembers and the public. Despite decades of research on fighting antibiotic resistance, new scientific understanding of the phenomenon remains a continued necessity. Discovering a mechanism for antibiotic resistance can present opportunities to design innovative therapeutic approaches to defeat bacterial infections and provide better protections for the servicemember and the nation.

    Bacterial antibiotic-resistance mechanisms are complex but have traditionally been categorized into three broad groups:

    • Target modification occurs when the bacteria alter themselves to avoid interacting with the medicine, such as in mutations or sharing resistance genes
    • Drug inactivation occurs when the bacteria render the medicine ineffective
    • Drug transport failure occurs when the medicine is unable to reach its intended target to kill the bacteria

    The researchers exposed actively growing E. coli to certain antibiotics that imposed selective pressures and enriched the survival of bacteria with mutations in the genes responsible for metabolism that had not been appreciated previously by scientists. By doing so, certain bacterial processes were minimized, such as respiration, which prevented the antibiotics from killing the bacteria and resulted in antibiotic resistance.

    The research team discovered that several metabolism-specific mutations are abundant in the genomes of more than 3,500 clinical E. coli pathogens.

    DTRA-JSTO’S DOMANE research expands the known processes for antibiotic resistance beyond the usual mechanisms. The discovery can be broadened beyond E.coli to bacterial biothreat agents, both endemic to certain geographic areas as well as those biologically engineered.

    Story adapted from DTRA Chemical and Biological Technologies Department

    Antimicrobials Defense Threat Reduction Agency E. coli Editor Pick
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleFirst-in-Class Nerve Agent Antidote Crosses Blood-Brain Barrier to Aid Central Nervous System
    Next Article Taking Aim at Alphaviruses

    Related Stories

    First Light Diagnostics Receives FDA Clearance for Rapid Anthrax Test

    December 5, 2023

    Chlorine Exposure Biomarkers in a Large Animal Model

    December 5, 2023

    ARPA-H Announces New Tiered Proposal Submission System to Reduce Applicant Barriers

    December 5, 2023

    Needle-Free Vaccine Patch Against Zika Virus

    December 2, 2023
    News Scan

    Biodefense Headlines – 30 November 2023

    News Scan November 30, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include the largest ever outbreak of mpox in the DRC; launch of National Wastewater Surveillance Program dashboard; low uptake of COVID-19 boosters and flu vaccines;…

    Upcoming Events

    Mar 12
    Hybrid Hybrid Event
    March 12, 2024 - March 17, 2024

    2024 Fungal Genetics Conference

    Mar 21
    March 21, 2024 - March 23, 2024

    ASPPH 2024 Annual Meeting

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    News on pathogens and preparedness for public health emergencies

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    Global Biodefense places cookies on your device to enable the best user experience. By using our website, you agree to placement of these cookies. To learn more, read our Privacy Policy.OKPrivacy Policy